Characterisation Of Eurl, A Novel Gene Implicated In The Etiology Of Abnormal Brain Development And Intellectual Disability
Funder
National Health and Medical Research Council
Funding Amount
$597,541.00
Summary
Intellectual disability affects around one per cent of Australians, and can arise from genetic abnormalities during fetal life, such as through abnormal regulation of gene expression. We have identified a novel gene, known as eurl, which controls brain assembly as well as the ability of neurons to form functional connections within the brain. We will investigate how this novel gene controls brain development, and characterise eurl as a potential therapeutic target for learning and memory.
The Long-term Consequences Of Assisted Reproduction On The Growth, Metabolic, Respiratory, Psychological, Immunological And Reproductive Development Of The Offspring.
Funder
National Health and Medical Research Council
Funding Amount
$1,552,096.00
Summary
1 in 25 children are born from IVF treatment - incredibly- to our shame; no data exists as to the long-term health of these children. Presented is a unique opportunity, which would be exceedingly difficult to replicate elsewhere in the world, to determine the long-term consequences of IVF upon the development of the offspring, by comparing their growth, metabolic, respiratory, psychological, immunological and reproductive development to a representative sample of WA children- the Raine cohort.
Using Systems Biology To Understand Asthma Exacerbations And Develop Better Treatments
Funder
National Health and Medical Research Council
Funding Amount
$791,734.00
Summary
Our research using cutting-edge technology has demonstrated that not all asthma attacks are the same. There are two major subtypes of asthma attacks. Currently, we use the same medication to treat all asthma attacks, and this medication targets the symptoms rather than the cause. This research will conduct detailed laboratory studies to understand what causes the two different types of asthma attacks, and test new treatments that are targeted and tailored to each type of asthma attack.